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Introduction
Renal fibrosis, particularly tubulointerstitial fibrosis, is a common pathophysiological pathway of several renal diseases leading to end-stage renal failure [1] [2] [3] . Renal fibrosis contributes to the pathophysiology of chronic kidney disease [1, 3] . Tubulointerstitial fibrosis is characterized by excessive accumulation of extracellular matrix (ECM) proteins, such as α-smooth muscle actin (α-Sma), collagen type I and fibronectin, leading to destruction of the functional tissue [1, 3, 4] . The increased production and deposition of ECM is mainly caused by myofibroblasts [5] , which may be recruited from resident fibroblasts, bone marrowderived cells or from epithelial to mesynchymal transition (EMT) [5, 6] .
Mechanisms involved in the regulation of ECM protein expression leading finally to ECM deposition include transforming growth factor β 1 (Tgfβ1) [1, 3, 4] . Tgfβ1 signaling seems to be a major pathway inducing fibroblast activation and proliferation [7] . In renal fibrosis, Tgfβ1-induced EMT is mediated via Smad2/3 phosphorylation and subsequent nuclear translocation [3] . Activation of the Tgfβ1/Smad pathway up-regulates plasminogen activator inhibitor 1 (Pai1) which is closely linked to the development of EMT and ECM deposition [3] . In addition to activation of Smad-dependent signaling pathways, Tgfβ1 activates various Smad-independent pathways to induce its pro-fibrotic effects [7] . Tgfβ-activated kinase 1 (Tak1) has been identified as a major non-canonical signaling molecule in Tgfβ1-mediated fibrosis [7] . Moreover, Tak1 participates in the regulation of Tgfβ1-induced activation of Smads [7] .
Tgfβ1, tumor necrosis factor α (Tnfα) and Pai1 are further implicated in excessive vascular remodeling, osteoinductive signaling and subsequent vascular calcification in klotho deficiency [8, 9] . According to recent observations, ammonium chloride (NH 4 Cl) treatment prevented tissue calcification and reduced vascular senescence in klotho-hypomorphic mice [8] . In those mice, the excessive expression of Tgfb1, transcription factor nuclear factor of activated T cells 5 (Nfat5), Nfat5-downstream mediator SRY (sex determining region Y)-box 9 (Sox9) and Pai1 was reversed following NH 4 Cl treatment. NH 4 Cl has previously been shown to interfere with Tgfβ1 [10] . Moreover, the expression of Sox9, a transcriptional regulator in the development of tissue fibrosis [11] was shown to be regulated by Tgfβ1 [12] and Tak1 [13] .
The present study thus explored the effect of NH 4 Cl treatment on renal Tgfβ1-dependent signaling and markers of fibrosis following obstructive nephropathy. To this end, mice were subjected to unilateral ureteral obstruction (UUO), a well established model to induce tubulointerstitial fibrosis [2, 14] , with or without NH 4 Cl treatment added to the drinking water [8] .
Materials and Methods

Animals
All animal experiments were conducted according to the German law for the welfare of animals and were approved by local authorities. Experiments have been performed in male mice (C57Bl6) at the age of 8 weeks. Mice had free access to food (Sniff) and tap drinking water. Where indicated, NH 4 Cl (0.28 M) was added to the drinking water 3 days before the surgical intervention and for the duration of the UUO treatment.
Unilateral ureteral obstruction
Renal fibrosis was induced by unilateral ureteral obstruction (UUO) [2] . Following surgical incision of the skin and abdominal wall, the left ureter was exposed and ligated twice with a non-resorbable 7-0 filament. Following ligation the surgical wound was closed by sutures. Mice were treated with metamizole for analgesia (200 mg/kg body weight) after the procedure and for the duration of the UUO experiment in drinking water. The mice were sacrificed 7 days after the ligation procedure and the obstructed as well as the non-obstructed kidney were rapidly removed and kidney tissues snap frozen in liquid nitrogen. 
Blood pH analysis
For blood pH analysis, the retro-orbital plexus was punctured with a heparinized capillary. The blood samples were injected directly from the capillary into a blood gas analyzer (i15 blood gas and chemistry analyzer, Edan) to determine blood pH.
Quantitative RT-PCR Total RNA was isolated from murine kidney tissues using Trifast Reagent (Peqlab) according to the manufacturer's instructions. Reverse transcription of 2 µg RNA was performed using oligo(dT) [12] [13] [14] [15] [16] [17] [18] The specificity of the PCR products was confirmed by analysis of the melting curves. All PCRs were performed in duplicate and relative mRNA fold changes were calculated by the 2 -ΔΔCt method using Gapdh as internal reference. Results are shown normalized to the mRNA expression in obstructed kidney tissues of control treated mice.
Extraction of nuclear and cytoplasmic proteins
Cytoplasmic and nuclear extracts were prepared using the NE-PER nuclear and cytoplasmic extraction reagents (Thermo Fisher Scientific) according to the manufacturer's instructions. Protein concentration was determined by Bradford assay (Biorad Laboratories) and 20 µg of protein were boiled in Roti-Load1 Buffer (Carl Roth) at 100°C for 5 min. Smad2 phosphorylation in the nuclear and cytoplasmic fractions were further determined by Western blot analysis.
Western blot analysis
Murine kidney tissues were lysed with ice-cold lysis buffer (Thermo Fisher Scientific) supplemented with complete protease and phosphatase inhibitor cocktail (Thermo Fisher Scientific). After centrifugation at 10000 rpm for 5 min, proteins were boiled in Roti-Load1 Buffer (Carl Roth) at 100ºC for 5 min. Proteins were separated on SDS-polyacrylamide gels and transferred to PVDF membranes. The membranes were incubated overnight at 4°C with the following primary antibodies: rabbit anti-α-smooth muscle actin, rabbit anti-collagen I (diluted 1:1000, Abcam), mouse anti-fibronectin (diluted 1:1000, BD Biosciences), rabbit anti-Tak1, rabbit anti-Smad2, rabbit anti-phosphorylated Smad2 (Ser 
Results
To explore whether NH 4 Cl treatment influences renal pro-fibrotic signaling following obstructive nephropathy, UUO was performed in C57Bl6 mice with or without additional treatment with NH 4 Cl. The mice were treated with 0.28 M NH 4 Cl in the drinking water 3 days before the obstructive injury and for the duration of the UUO treatment. Seven days after the obstructive injury, the animals were sacrificed and the obstructed kidney tissues were compared between the treatment groups. NH 4 Cl treatment significantly (p<0.01) decreased blood pH from 7.37 ± 0.03 to 7.20 ± 0.04 (n=5). 
Cellular Physiology and Biochemistry
Based on previous observations, Tgfβ1 signaling was investigated in renal obstructive injury. As shown in Fig. 1A , Tgfb1 mRNA expression was higher in the obstructed kidney tissues than in non-obstructed control kidney tissues following UUO. The increased Tgfb1 mRNA levels were significantly decreased in the obstructed kidney tissues from NH 4 Cl treated mice as compared to control treated mice (Fig. 1A) . The effects of NH 4 Cl treatment on renal Tgfb1 expression were paralled by a significant reduction of the increased Tak1 protein levels in the obstructed kidney tissues (Fig. 1B) . Moreover, the increased Smad2 phosphorylation at Ser 465/467 in the nuclear fraction isolated from obstructed kidney tissues following UUO was significantly decreased in NH 4 Cl treated mice as compared to control treated mice ( Fig. 2A,  B) . No significant effects of NH 4 Cl treatment on Smad2 phosphorylation in the cytoplasmic fraction isolated from the obstructed kidney tissues were observed ( Fig. 2A, C) . In nonobstructed control kidney tissues, NH 4 Cl treatment did not significantly modify Tgfb1 and Tak1 expression (Fig. 1) or Smad2 phosphorylation (Fig. 2) .
To further define the effects of NH 4 Cl on Tgfβ1-mediated pro-fibrotic signaling following UUO, the mRNA expression of the transcription factors Nfat5 and Sox9 was determined. Following UUO, Nfat5 and Sox9 mRNA levels were increased in the obstructed kidney tissues as compared to non-obstructed control kidney tissues, effects significantly suppressed following treatment with NH 4 Cl (Fig. 3A, B) . NH 4 Cl treatment did not significantly modify Nfat5 and Sox9 mRNA levels in the non-obstructed control kidney tissues (Fig. 3A, B) . )/Smad2 to Hdac2 or α-tubulin protein ratio in the nuclear fraction and cytoplasmic fraction respectively, in renal tissue from non-obstructed control kidney (CTR) and obstructed kidney (UUO) following 7 days of unilateral ureteral obstruction (UUO) in control treated mice (ctr; white bars) and in mice treated with NH 4 Cl (0.28 M NH 4 Cl added to the drinking water; black bars). *(p<0.05) statistically significant vs respective kidney tissues of control treated mice.
significantly modify Tnfa, Il6, Pai1 and Snai1 mRNA expression in the non-obstructed control kidney tissues (Fig. 4) .
In order to quantify the effect of NH 4 Cl treatment on markers of the fibrotic response following UUO, the expression of α-Sma, fibronectin and collagen type I was determined. As a result, the increased α-Sma (Fig. 5A), fibronectin (Fig. 5B ) and collagen type I (Fig. 5C ) protein expression in obstructed kidney tissues following UUO were significantly reduced in NH 4 Cl treated mice as compared to control treated mice. Accordingly, NH 4 Cl treatment significantly blunted the increased renal mRNA expression of α-Sma (Fig. 5D) , fibronectin (Fbn) (Fig. 5E ) and collagen type I (Col1a1) (Fig. 5F ) in obstructed kidney tissues following UUO. In non-obstructed control kidney tissues, NH 4 Cl treatment did not significantly affect renal α-Sma, fibronectin and collagen type I protein expression and Fbn and Col1a1 mRNA levels but significantly increased renal α-Sma mRNA expression (Fig. 5) .
Discussion
The present study reveals a suppressive effect of NH 4 Cl treatment on the signaling of renal interstitial fibrosis following UUO. NH 4 Cl treatment significantly blunted the increase of renal α-Sma, a mesenchymal marker mainly expressed by activated fibroblasts and myofibroblasts [5] . Consistent with reduced α-Sma abundance following obstructive injury, renal expression of ECM proteins such as fibronectin and collagen type 1 were mitigated in the mice treated with NH 4 Cl. In the development of renal fibrosis, Tgfβ1 is regarded as the most relevant pro-fibrotic cytokine [7] . Similar to previous findings [8] , NH 4 Cl treatment inhibited UUO-induced upregulation of Tgfb1 mRNA expression in the obstructed kidney tissues. Dietary treatment with NH 4 Cl leads to acidosis [15] . Moreover, NH 4 + may further dissociate to H + and NH 3 , which permeates membranes and thus enters cells and cellular compartments [16] . NH 3 may bind H + and may thus be trapped as NH 4 + within acidic cellular compartments [17] . The binding of H + alkalinizes those compartments [17] . By alkalinizing lysosomes, NH 4 Cl has previously been shown to interfere with Tgfβ1 maturation [10] .
The effects of NH 4 Cl on Tgfb1 expression were paralleled by inhibition of increased Tak1 protein levels and of increased nuclear phosphorylated Smad2, downstream signaling mediators of Tgfβ1 [3, 18] . Moreover, NH 4 Cl treatment reduces the increased expression of the pro-fibrotic Tgfβ1 target genes: Tnfa, Il6, Pai1 and Snai1 following obstructive injury.
Beyond that, the cellular accumulation of NH 4 + with Cl -may lead to cell swelling [19] which suppresses expression of the cell volume sensitive transcription factor TONEBP (Tonicity-Responsive Enhancer Binding Protein) or Nfat5 [20] . Accordingly, NH 4 Cl treatment significantly blunted UUO-induced renal Nfat5 expression. Tgfβ1 up-regulates Nfat5 expression [21] . Nfat5 was in turn shown to up-regulate Tnfα and Il6 in immune cells [22] . On the other hand, Nfat5 was shown to regulate the expression of several collagen subtypes [23] and chondrogenic differentiation dependent on Sox9 [23] , a key transcription factor also in the development of fibrosis [11] . Previous studies show that Sox9 expression is up-regulated by Tgfβ1 [12] and Tak1 [13] .
Tgfβ is decisive in the triggering of fibrosis of the kidney [3] . Tgfβ may be effective through serum-and glucocorticoid-inducible kinase 1 (Sgk1) and Akt [24] . Sgk1 expression is sharply up-regulated by cell shrinkage [24] . Tgfβ significantly contributes to the stimulation of renal fibrosis following UUO [4] . Sgk1 is at least in part effective by phosphorylating glycogen synthase kinase 3 (Gsk-3) [14] , which is accomplished by Sgk and Akt isoforms [25] .
NH 4 Cl similarly interferes with Tgfβ1 signaling in vascular tissue during hyperphosphatemia [8] . Moreover, renal dysfunction following 5/6 nephrectomy is ameliorated by NH 4 Cl treatment [26] . The renoprotective effects of NH 4 Cl drinking solution were independent of phosphate [27] . According to these observations, NH 4 Cl may have beneficial properties in renal disease. On the other hand acidosis has been shown to aggravate and alkali treatment to delay progression of chronic kidney disease [28, 29] .
Conclusion
Tgfβ1 signaling leading to renal tissue fibrosis may be counteracted by NH 4 Cl treatment, an observation possibly opening novel therapeutic opportunities.
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